Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Medicine (Baltimore) ; 101(45): e31603, 2022 Nov 11.
Article in English | MEDLINE | ID: mdl-36397420

ABSTRACT

We conducted a cross-sectional study of patient safety culture aimed at examining the factors that influence patient safety culture in university hospitals under a universal health insurance system. The Hospital Survey on Patient Safety Culture developed by the Agency for Healthcare Research and Quality was used. The survey was distributed to 1066 hospital employees, and 864 responded. The confirmatory factor analysis showed a good fit of the results to the 12-composites model. The highest positive response rates were for "(1) Teamwork within units" (81%) and "(2) Supervisor/manager expectations and actions promoting patient safety" (80%), and the lowest was for "(10) Staffing" (36%). Hayashi's quantification theory type 2 revealed that working hours per week had the greatest negative impact on patient safety culture. Under a universal health insurance system, workload and human resources might have a significant impact on the patient safety culture.


Subject(s)
Organizational Culture , Patient Safety , Humans , Cross-Sectional Studies , Hospitals, University , Universal Health Insurance , Japan , Safety Management
2.
Arts Health ; : 1-11, 2018 Jan 05.
Article in English | MEDLINE | ID: mdl-31038446

ABSTRACT

BACKGROUND: Recently, arts and health activities have been introduced into health care, and evidence of their effectiveness has been accumulating. However, few studies have examined this subject in Japan. METHODS: In this practice-based report, faculty of a Japanese school of medicine and a university of arts and design collaborated to explore the effectiveness of an arts and health approach in three different patient safety educational programs implemented in different university hospitals in Japan. RESULTS: The results of the programs demonstrated the effectiveness of integrating arts and health into patient safety management. CONCLUSIONS: Additional research is required to understand this further.

3.
Pflugers Arch ; 455(2): 223-39, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17562070

ABSTRACT

Intracellular pH (pHi) after the NH+4 pulse addition and its removal were measured in isolated alveolar type II cells (ATII cells) using BCECF fluorescence. In the absence of HCO(-3), the NH+4 pulse addition increased pHi (alkali jump) and its removal decreased pH(i) (acid jump) to the control level (no overacidification). This pHi change was induced by reaction 1 (NH3 + H+ <--> NH+4). However, in the presence of HCO(-3), the NH+4 pulse removal decreased pHi (acid jump) with overacidification. The extent of overacidification was decreased by acetazolamide (a carbonic anhydrase inhibitor), bumetanide (an inhibitor of Na+/K+/2Cl(-) cotransporter [NKCC]), and NPPB (an inhibitor of Cl(-) channel). The NH+4 pulse addition led to the accumulation of NH+4 in ATII cells via reaction 1 and NKCC, and the NH+4 pulse removal induced reaction 2 (NH+4 + HCO(-3) --> NH3 + H+ HCO(-3)) in addition to the reversal of reaction 1. Thus, NH+4 that entered via NKCC reacts with HCO(-3) (reaction 2) to produce H+, which induces overacidification in the acid jump. After the overacidification, the pH(i) recovery consisted of a rapid recovery (first phase) followed by a slow recovery (second phase). The first phase was inhibited by NPPB, glybenclamide, amiloride, and an Na+-free solution, and the second phase was inhibited by DIDS, MIA, and an Na+-free solution. Both phases were accelerated by a high extracellular HCO(-3) concentration. These observations indicate that the first phase was induced by HCO(-3) entry via Cl(-) channels coupled with Na+ channels activities, and that the second phase was induced by H+ extrusion via Na+/H+ exchanger and by HCO(-3) entry via HCO(-3) cotransporter. Thus, in ATII cells, HCO(-3) entry via Cl(-) channels is essential for recovering pHi after overacidification during the acid jump and for removing NH+4 that entered via NKCC from ATII cells, suggesting HCO(-3)-dependent NH3 excretion from lungs.


Subject(s)
Ammonia/metabolism , Bicarbonates/metabolism , Pulmonary Alveoli/metabolism , Quaternary Ammonium Compounds/metabolism , 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid/pharmacology , Acetazolamide/pharmacology , Amiloride/pharmacology , Animals , Bumetanide/pharmacology , Carbonic Anhydrases/drug effects , Carbonic Anhydrases/metabolism , Chloride Channels/antagonists & inhibitors , Chloride Channels/metabolism , Enzyme Inhibitors/pharmacology , Glyburide/pharmacology , Hydrogen-Ion Concentration , Macrolides/pharmacology , Male , Nitrobenzoates/pharmacology , Rats , Rats, Wistar , Sodium Potassium Chloride Symporter Inhibitors , Sodium-Potassium-Chloride Symporters/metabolism
4.
Article in English | MEDLINE | ID: mdl-16707281

ABSTRACT

To screen cancer for specific autoantibodies, we applied the approach established by Brichory et al., who reported annexins I and II as specific antigens. Solubilized proteins from a cancer cell line (A549) were separated using two-dimensional polyacrylamide gel electrophoresis (2D-PAGE), followed by Western blotting (WB) analysis, in which the sera of individual patients were tested for primary antibodies. We found 11 positive spots on PVDF membrane using a WB/enhanced chemiluminescence detection Kit, and identified eight proteins, such as alpha-enolase, inosine-5'-monophosphate dehydrogenase, aldehyde dehydrogenase, 3-phosphoglycerate dehydrogenase, 3-oxoacid CoA transferase, chaperonin, peroxiredoxin 6 and triosephosphate isomerase, that reacted with these antibodies in patients' sera using MALDI-TOF/TOF. All eight antibodies were not detected in the sera derived from lung tuberculosis and healthy controls.


Subject(s)
Antibodies, Neoplasm/analysis , Neoplasm Proteins/immunology , Proteomics/methods , Adenocarcinoma/immunology , Adenocarcinoma/pathology , Antibodies, Neoplasm/blood , Autoantibodies/analysis , Autoantibodies/blood , Blotting, Western/methods , Cell Line, Tumor , Electrophoresis, Gel, Two-Dimensional/methods , Humans , Lung Neoplasms/immunology , Lung Neoplasms/pathology , Phosphopyruvate Hydratase/immunology , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
5.
Exp Physiol ; 90(2): 203-13, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15640277

ABSTRACT

The effects of intracellular Ca2+ concentration, [Ca2+]i, on the volume of rat alveolar type II cells (AT-II cells) were examined. Perfusion with a Ca2+-free solution induced shrinkage of the AT-II cell volume in the absence or presence of amiloride (1 microm, an inhibitor of Na+ channels); however, it did not in the presence of 5-(N-methyl-N-isobutyl)-amiloride (MIA, an inhibitor of Na+-H+ exchange). MIA decreased the volume of AT-II cells. Inhibitors of Cl(-)-HCO3- exchange, 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS) and 4-acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic acid (SITS) also decreased the volume of AT-II cells. This indicates that the cell shrinkage induced by a Ca2+-free solution is caused by a decrease in NaCl influx via Na+-H+ exchange and Cl(-)-HCO3- exchange. Addition of ionomycin (1 microm), in contrast, induced cell swelling when AT-II cells were pretreated with quinine and amiloride. This swelling of the AT-II cells is not detected in the presence of MIA. Intracellular pH (pHi) measurements demonstrated that the Ca2+-free solution or MIA decreases pHi, and that ionomycin increases it. Ionomycin stimulated the pHi recovery after an acid loading (NH4+ pulse method), which was not noted in MIA-treated AT-II cells. Ionomycin increased [Ca2+]i in fura-2-loaded AT-II cells. In conclusion, the Na+-H+ exchange activities of AT-II cells, which maintain the volume and pHi, are regulated by [Ca2+]i.


Subject(s)
Calcium/metabolism , Pulmonary Alveoli/physiology , Sodium Chloride/metabolism , Sodium-Hydrogen Exchangers/physiology , Water-Electrolyte Balance/physiology , Animals , Biological Transport, Active/physiology , Cell Size , Cells, Cultured , Homeostasis/physiology , Hydrogen-Ion Concentration , Male , Rats , Rats, Wistar
6.
Exp Physiol ; 89(4): 373-85, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15123552

ABSTRACT

Terbutaline (10 microm) induced a triphasic volume change in alveolar type II (AT-II) cells: an initial shrinkage (initial phase) followed by cell swelling (second phase) and a gradual shrinkage (third phase). The present study demonstrated that the initial and the third phases are evoked by the activation of K+ and Cl- channels and the second phase is evoked by the activation of Na+ and Cl- channels. Ouabain blocked the third phase, although it did not block the initial and second phases. This suggests that the third phase is triggered by the Na+-K+ pump. Tetraethylammonium (TEA, a K+ channel blocker) decreased the volume of AT-II cells and enhanced the terbutaline-stimulated third phase, although quinidine, another K+ channel blocker, increased the volume of AT-II cells. The TEA-induced cell shrinkage was inhibited by ouabain, suggesting that TEA increases Na+-K+ pump activity. Ba2+, 2,3-diaminopyridine and a high [K+]o (30 mm) similarly decreased the volume of AT-II cells. These findings suggest that depolarization induced by TEA increases Na+-K+ pump activity, which increases [K+]i. This [K+]i increase, in turn, hyperpolarizes membrane potential. Valinomycin (a K+ ionophore), which induces hyperpolarization, decreased the volume of AT-II cells and enhanced the third phase in these cells. In conclusion, in terbutaline-stimulated AT-II cells, an increase in Na+-K+ pump activity hyperpolarizes the membrane potential and triggers the third phase by switching net ion transport from NaCl entry to KCl release.


Subject(s)
Amiloride/analogs & derivatives , Pulmonary Alveoli/metabolism , Sodium-Potassium-Exchanging ATPase/metabolism , Sympathomimetics/pharmacology , Terbutaline/pharmacology , Water-Electrolyte Balance/physiology , Amiloride/pharmacology , Animals , Enzyme Inhibitors/pharmacology , Ionophores/pharmacology , Male , Ouabain/pharmacology , Potassium/pharmacokinetics , Potassium Channel Blockers/pharmacology , Pulmonary Alveoli/cytology , Rats , Rats, Wistar , Sodium/pharmacokinetics , Sodium Channel Blockers/pharmacology , Sodium-Potassium-Exchanging ATPase/antagonists & inhibitors , Tetraethylammonium/pharmacology , Valinomycin/pharmacology , Water-Electrolyte Balance/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...